Cell Death and Disease · 2023 · 11 citations · 38 references
MedicineCancer BiologyOncologyEpigeneticsMolecular OncologyTranscriptional RegulationCancer Cell SignalingCancer EpigeneticsEpigenetic Regulation In CancerEpithelial-mesenchymal TransitionEpithelial-to-mesenchymal TransitionHistone ModificationsCancer OrganoidsHistone AcetylationHistone-lysine AcetylationMammary Epithelial OrganoidsMesenchymal TransitionProtein Subcellular LocalizationTransforming Growth Factor Beta RegulationTransforming Growth Factor-beta Signaling
Protein post-translational modification by the small ubiquitin-like modifier (SUMO) regulates the stability, subcellular localization, and interactions of protein substrates with consequences on cellular responses including epithelial-mesenchymal transition (EMT). Transforming growth factor beta (TGFβ) is a potent inducer of EMT with implications for cancer invasion and metastasis. The transcriptional coregulator SnoN suppresses TGFβ-induced EMT-associated responses in a sumoylation-dependent manner, but the underlying mechanisms have remained largely unknown. Here, we find that sumoylation promotes the interaction of SnoN with the epigenetic regulators histone deacetylase 1 (HDAC1) and histone acetylase p300 in epithelial cells. In gain and loss of function studies, HDAC1 suppresses, whereas p300 promotes, TGFβ-induced morphogenetic changes associated with EMT-related events in three-dimensional multicellular organoids derived from mammary epithelial cells or carcinomas. These findings suggest that sumoylated SnoN acts via the regulation of histone acetylation to modulate EMT-related effects in breast cell organoids. Our study may facilitate the discovery of new biomarkers and therapeutics in breast cancer and other epithelial cell-derived cancers.
38
Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein
Shannon L. Stroschein, Wei Wang, Sharleen Zhou et al. · Science · 1999 · 494 citations